Santen Pharmaceutical Co Ltd 2019 Annual Report with Sustainability Disclosures
The report describes Santen's global ophthalmology focus and consolidated FY2018 revenue of ¥234,026 million. It highlights a Group-wide CSR Committee responsible for setting CSR policies and targets and monitoring progress. The report also states that there were no work-related fatalities across all regions, including contract and temporary employees.
Company: Santen Pharmaceutical Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2019
Type: Annual Report with Sustainability Disclosures
Pages: 60
Back to company
Santen Pharmaceutical Co Ltd
Annual Report
The report describes Santen's global ophthalmology focus and consolidated FY2018 revenue of ¥234,026 million. It highlights a Group-wide CSR Committee responsible for setting CSR policies and targets and monitoring progress. The report also states that there were no work-related fatalities across all regions, including contract and temporary employees.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2019
Reporting Period
Apr 1, 2018 - Mar 31, 2019
Fiscal Year
2018
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Water Consumption
Total Waste
Women in Management
Workplace Fatalities
Employees